                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Actives Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \section{Cleaning Agent Limit Calculations}section text here\subsection{Febuxostat Tablets 40 mg 80 mg and 120 mg (Pr1)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Telmisartan Tablets 20 mg 40 mg and 80 mg (Pr3)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Rosuvastatin Calcium Tablets 5 mg 10 mg 20 mg and 40 mg (Pr4)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg and 300 mg (Pr5)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    \subsection{Test Product (Pr6)}some text hereWorst SAL: 0.725 mg/sqcmNext Production: Dabigatran Etexilate Capsules 75 mg 110 mg and 150 mg (Pr2)Next PSwab Limit: 1813.458 ppm Swab Area: 25 sqcm Swab Volume: 10 ml\begin{tabular}{ | l | l | l|}\hline    Previous API(A) & Next Production & ID (B)\\    \hline    1 & Pr1 & Pr1\\    \hline    2 & Pr2 & Pr2\\    \hline    3 & Pr3 & Pr3\\    \hline    4 & Pr4 & Pr4\\    \hline    \end{tabular}\\[0.5in]    \textbf{Shared Area Calculation for Pr1 and Pr2}\\[0.1in]\begin{tabular}{ | l | l|}\hline    Equipment & Largest Surface Area\\    \hline    Scoop (DAPR009) & 300\\    \hline    Scoop (DAWH001) & 300\\    \hline    \end{tabular}\\[0.5in]    